In the Zone: overcoming hurdles for iChem workflow automation

Challenges within the pharmaceutical industry including clinical study mix, sample volumes and virtualization, unique assays, talent scarcity and rising cost pressures on lab performance, have increased the need for automation in immunochemistry. While initial automation test results confirm the benefits of sample throughput, turnaround time and laboratory staff efficiencies within immunochemistry, unanticipated method validation complexities between automated and manual processes have arisen.


INFOGRAPHIC

INZ CAR-TiChem Workflow – Current advancements in automation and future hurdles
This infographic highlights the challenges faced within immunochemistry and how these have driven the development of more efficient immunochemistry automation platforms that will overcome these hurdles.

 

 

INTERVIEW

podcast

The hurdles and highlights of immunochemistry workflow automation: an interview with Andrew Hall

In this interview, expert Andrew Hall from Labcorp Bioanalytical Services (Leeds, UK) provides an overview of the efficiencies and challenges experienced with immunochemistry automation and the future outlook for workflow automation.

 

 

RESOURCES

Bioanalysis Zone hexagon

Introducing automation to a regulated laboratory – an experience report

Autonomous phlebotomy device stands at the precipice of new era for medical robotics

Bridging immunogenicity assays for IgG4 therapeutics: mitigating interference from Fc–Fc interactions

 

 


In association with: